References
- Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics 2007. CA Cancer J Clin 2007; 57: 43–66
- Heney NM, Ahmed S, Flanigan MJ, Frable W, Corder MP, Hafermann MD, et al. Superficial bladder cancer: progression and recurrence. J Urol 1983; 130: 1083–6
- Narayana AS, Loening SA, Slymen DJ, Culp DA. Bladder cancer: factors affecting survival. J Urol 1983; 130: 56–60
- Herr HW. Progression of stage T1 bladder tumours after intravesical bacillus Calmette-Guerin. J Urol 1991; 145: 40–3
- Matzkin H, Soloway MS, Hardeman S. Transitional cell carcinoma of the prostate. J Urol 1991; 146: 1207–12
- Millan-Rodriquez F, Chechile-Toniolo G, Salvador-Bayarri J, Palou J, Vincente-Rodriguez J, et al. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 2000; 163: 73–8
- Kiemeney LA, Witjes JA, Heijbroek RP, Verbeek AL, Debruyne FM, et al. Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer. J Urol 1993; 150: 60–4
- Cheng L, Neumann RM, Scherer BG, Weaver AL, Leiborich BC, Nehra A, et al. Tumour size predicts the survival of patients with pathologic stage T2 bladder carcinoma. Cancer 1999; 85: 2638–47
- Pollock A, Zagars GK, Cole CJ, Dinney CPN, Swanson DA, von Eschenbath AC. Preoperative radiotherapy for muscle invasive bladder carcinoma. Long-term follow-up and prognostic factors for 338 patients. Cancer 1994; 74: 2819–27
- Fung CY, Shipley WU, Young RH, Griffin PP, Convery KM, Kaufman DS, et al. Prognostic factors in invasive bladder carcinoma in a prospective trial of preoperative adjuvant chemotherapy and radiotherapy. J Clin Oncol 1991; 9: 1533–42
- Fitzpatrick JM, West AB, Butler MR, Lane V, O'Flynn JD. Superficial bladder tumours (stage pTa. Grades 1 and 2): the importance of recurrence pattern following initial resection. J Urol 1986; 136: 920–2
- Witjes JA, Kiemeney LA, Schaafsma HE, Debruyn FM. The influence of review pathology on study outcome of a randomized multicentre superficial bladder cancer trial. Br J Urol 1994; 73: 172–6
- Mulders PF, Mayden AP, Doesburg WH, Oosterhof GO, Debruyne FM. Prognostic factors in pTa-pT1 superficial bladder tumours treated with intravesical instillations. The Dutch South-Eastern Urological Collaborative Group. Br J Urol 1994; 73: 403–8
- Prout GR, Barton BA, Griffin PP, Friedell G. Treated history of non invasive grade 1 transitional cell carcinoma. J Urol 1992; 148: 1413–9
- Cookson MS, Sarosdy MF. Management of stage T1 superficial bladder cancer with intravesical bacillus, Calmette-Guerin therapy. J Urol 1992; 148: 797–801
- Flamm J, Havelec L. Factors affecting survival in primary superficial bladder cancer. Eur Urol 1990; 17: 113–8
- Freeman JA, Esrig D, Stein JP, Simoneau AR, Skinner EC, Chen SC, et al. Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction. Cancer 1995; 76: 833–9
- Amling CL, Thrasher JB, Frazier HA, Dodge RK, Robertson JE, Paulson DF. Radical cystectomy for stage Ta, Tis and T1 transitional cell carcinoma of the bladder. J Urol 1994; 151: 31–5
- Dutta SC, Smith JA, Shappell BS, Coffey CS, Chang SS, Cookson MS. Clinical under staging of high risk invasive urothelial carcinoma treated with radical cystectomy. J Urol 2001; 166: 490–3
- Jakse G, Algaba F, Malmstrom P, Oosterlinck W. A second-look TUR in T1 transitional cell carcinoma: why?. Eur Urol 2004; 45: 539–46